bromocriptine has been researched along with Anesthesia Related Hyperthermia in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (87.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gillman, PK | 1 |
Hippius, H; Spiess-Kiefer, C | 1 |
Levenson, JL | 1 |
Keltner, NL; McIntyre, CW | 1 |
Rampertaap, MP | 1 |
Baxter, LR; Guzé, BH | 1 |
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G | 1 |
Lucid, EJ; Martin, ML; Walker, RW | 1 |
3 review(s) available for bromocriptine and Anesthesia Related Hyperthermia
Article | Year |
---|---|
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Child; Dantrolene; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Female; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Receptors, Dopamine; Rhabdomyolysis; Schizophrenia | 1985 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differential; Female; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia, Paranoid; Time Factors | 1986 |
Current concepts. Neuroleptic malignant syndrome.
Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Drug Interactions; Heat Exhaustion; Humans; Malignant Hyperthermia; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Parasympatholytics | 1985 |
5 other study(ies) available for bromocriptine and Anesthesia Related Hyperthermia
Article | Year |
---|---|
The nature of hyperthermia in neuroleptic malignant syndrome and the use of bromocriptine.
Topics: Bromocriptine; Dopamine Agonists; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome | 2010 |
[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
Topics: Adult; Amantadine; Bromocriptine; Calcium; Cross-Sectional Studies; Dantrolene; Female; Humans; Ion Channels; Male; Malignant Hyperthermia; Muscle Contraction; Muscular Diseases; Neuroleptic Malignant Syndrome; Risk | 1986 |
Neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Catatonia; Diagnosis, Differential; Female; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome | 1985 |
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine | 1985 |
Neuroleptic malignant syndrome.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Diagnosis, Differential; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome | 1985 |